188 related articles for article (PubMed ID: 15345185)
21. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.
Richeldi L; Sorrentino R; Saltini C
Science; 1993 Oct; 262(5131):242-4. PubMed ID: 8105536
[TBL] [Abstract][Full Text] [Related]
22. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
Fontenot AP; Maier LA
Trends Immunol; 2005 Oct; 26(10):543-9. PubMed ID: 16099719
[TBL] [Abstract][Full Text] [Related]
23. Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis.
Chou YK; Edwards DM; Weinberg AD; Vandenbark AA; Kotzin BL; Fontenot AP; Burrows GG
J Immunol; 2005 Apr; 174(7):4316-24. PubMed ID: 15778396
[TBL] [Abstract][Full Text] [Related]
24. A genetic marker for chronic beryllium disease.
Saltini C; Richeldi L
Med Lav; 1995; 86(3):226-8. PubMed ID: 7565282
[No Abstract] [Full Text] [Related]
25. Immunogenetic basis of environmental lung disease: lessons from the berylliosis model.
Saltini C; Amicosante M; Franchi A; Lombardi G; Richeldi L
Eur Respir J; 1998 Dec; 12(6):1463-75. PubMed ID: 9877510
[TBL] [Abstract][Full Text] [Related]
26. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.
McCanlies EC; Ensey JS; Schuler CR; Kreiss K; Weston A
Am J Ind Med; 2004 Aug; 46(2):95-103. PubMed ID: 15273960
[TBL] [Abstract][Full Text] [Related]
27. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.
Rosenman KD; Rossman M; Hertzberg V; Reilly MJ; Rice C; Kanterakis E; Monos D
Occup Environ Med; 2011 Jul; 68(7):487-93. PubMed ID: 21186201
[TBL] [Abstract][Full Text] [Related]
28. Beryllium sensitivity is linked to HLA-DP genotype.
Wang Z; Farris GM; Newman LS; Shou Y; Maier LA; Smith HN; Marrone BL
Toxicology; 2001 Aug; 165(1):27-38. PubMed ID: 11551429
[TBL] [Abstract][Full Text] [Related]
29. Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells.
Amicosante M; Berretta F; Dweik R; Saltini C
Immunology; 2009 Sep; 128(1 Suppl):e462-70. PubMed ID: 19191908
[TBL] [Abstract][Full Text] [Related]
30. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.
Fontenot AP; Newman LS; Kotzin BL
Clin Immunol; 2001 Jul; 100(1):4-14. PubMed ID: 11414740
[No Abstract] [Full Text] [Related]
31. Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.
Fontenot AP; Falta MT; Kappler JW; Dai S; McKee AS
J Immunol; 2016 Jan; 196(1):22-7. PubMed ID: 26685315
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.
McCleskey TM; Buchner V; Field RW; Scott BL
Rev Environ Health; 2009; 24(2):75-115. PubMed ID: 19658317
[TBL] [Abstract][Full Text] [Related]
33. Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cells.
Fontenot AP; Keizer TS; McCleskey M; Mack DG; Meza-Romero R; Huan J; Edwards DM; Chou YK; Vandenbark AA; Scott B; Burrows GG
J Immunol; 2006 Sep; 177(6):3874-83. PubMed ID: 16951350
[TBL] [Abstract][Full Text] [Related]
34. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease.
Maier LA; Sawyer RT; Bauer RA; Kittle LA; Lympany P; McGrath D; Dubois R; Daniloff E; Rose CS; Newman LS
Am J Respir Crit Care Med; 2001 Oct; 164(7):1192-9. PubMed ID: 11673208
[TBL] [Abstract][Full Text] [Related]
35. T cell recognition of beryllium.
Dai S; Falta MT; Bowerman NA; McKee AS; Fontenot AP
Curr Opin Immunol; 2013 Dec; 25(6):775-80. PubMed ID: 23978481
[TBL] [Abstract][Full Text] [Related]
36. Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity.
Dotti C; D'Apice MR; Rogliani P; Novelli G; Saltini C; Amicosante M
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Mar; 21(1):29-34. PubMed ID: 15127972
[TBL] [Abstract][Full Text] [Related]
37. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals.
Sato H; Spagnolo P; Silveira L; Welsh KI; du Bois RM; Newman LS; Maier LA
Tissue Antigens; 2007 Dec; 70(6):480-6. PubMed ID: 17927685
[TBL] [Abstract][Full Text] [Related]
38. Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease.
Fontenot AP; Edwards DM; Chou YK; Mack DG; LaTocha D; Vandenbark AA; Burrows GG
Eur J Immunol; 2006 Apr; 36(4):930-9. PubMed ID: 16552706
[TBL] [Abstract][Full Text] [Related]
39. To Be2+ or not to Be2+: immunogenetics and occupational exposure.
Newman LS
Science; 1993 Oct; 262(5131):197-8. PubMed ID: 8105535
[No Abstract] [Full Text] [Related]
40. Genetic determinants of sensitivity to beryllium in mice.
Tarantino-Hutchison LM; Sorrentino C; Nadas A; Zhu Y; Rubin EM; Tinkle SS; Weston A; Gordon T
J Immunotoxicol; 2009 Jun; 6(2):130-5. PubMed ID: 19589099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
